drugset / Trial / NCT00785317

Effects of Estradiol on Menopausal Breast

NCT00785317

Phase 4 Unknown 120 enrolled Karolinska Institutet
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects on breast in postmenopausal women randomized to either oestradiol in combination with DRSP or E2 in combination with NETA during six months.

Timeline

Start
2008-11
Primary completion
2009-10
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 1 mg Oral
Subject Noresthisterone Acetate Unknown 0.5 mg Oral
Subject drospirenone Unknown 2 mg Oral

Indications

No indication recorded.